Graham P. Collins
Churchill Hospital(GB)University of Oxford(GB)Oxford University Hospitals NHS Trust(GB)Cancer Research UK Oxford Centre(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma(2018)1,085 cited
- → Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial(2016)915 cited
- → Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial(2018)738 cited
- → COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study(2020)599 cited
- → Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma(2018)357 cited
- →